Heritage Global Patents & Trademarks to Conduct Global Sealed-Bid Auction of Cancer Therapeutic Patent Portfolio
Heritage Global Patents & Trademarks to Conduct Global Sealed-Bid Auction of Cancer Therapeutic Patent Portfolio Therapies for the Treatment of Tumor, Autoimmune Diseases and Other Diseases |
[08-July-2020] |
SAN DIEGO, July 8, 2020 /PRNewswire/ -- Affigen's Cancer Therapeutic Patent Portfolio addresses: The Problem: The Signature Receptor is often unique from patient-to-patient necessitating a new drug for each patient within a clinically relevant time frame. The Solution: The Signature Platform enables the production of patient-specific therapies against Signature Receptors with unprecedented speed and precision. These therapies have the potential to bring a new class of safe and effective options to patients with Cancers, Autoimmune Diseases and Lymphoproliferative Disorders View Technology Summary About Heritage Global Inc. www.hginc.com About Heritage Global Patents & Trademarks
Contact: View original content to download multimedia:http://www.prnewswire.com/news-releases/heritage-global-patents--trademarks-to-conduct-global-sealed-bid-auction-of-cancer-therapeutic-patent-portfolio-301090010.html SOURCE Heritage Global Patents & Trademarks | ||
Company Codes: CNSX:HGP, OTC-PINK:HGBL, OTC-QB:HGBL |
© 2020 PR Newswire. All Rights Reserved.